Literature DB >> 19785972

Guanfacine extended release in the treatment of attention-deficit/hyperactivity disorder.

Anthony L Rostain1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19785972     DOI： 10.1007/s11920-009-0063-4

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN： 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  3 in total

1.  Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder.

Authors:  F B Taylor; J Russo
Journal:  J Clin Psychopharmacol       Date:  2001-04       Impact factor: 3.153

2.  A placebo-controlled study of guanfacine in the treatment of children with tic disorders and attention deficit hyperactivity disorder.

Authors:  L Scahill; P B Chappell; Y S Kim; R T Schultz; L Katsovich; E Shepherd; A F Arnsten; D J Cohen; J F Leckman
Journal:  Am J Psychiatry       Date:  2001-07       Impact factor: 18.112

3.  Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.

Authors:  P B Chappell; M A Riddle; L Scahill; K A Lynch; R Schultz; A Arnsten; J F Leckman; D J Cohen
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1995-09       Impact factor: 8.829
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.